Mixed responses to targeted therapy driven by chromosomal instability through p53 dysfunction and genome doubling

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Nature Communications

Topics

Biology

Cancer Oncology

Medicine

Cancer Research

Pulmonary And Respiratory Medicine

Show all topics

DOI

10.1038/s41467-024-47606-9

License

CC-BY

Other Formats

PDF